Phase 1 Study of a Sulforaphane-Containing Broccoli Sprout Homogenate for Sickle Cell Disease
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Phase 1 Study of a Sulforaphane-Containing Broccoli Sprout Homogenate for Sickle Cell Disease
Authors
Keywords
Ingestion, Hemoglobin, Red blood cells, Adverse events, Oxidative stress, Abdominal pain, Creatinine, Sickle cell disease
Journal
PLoS One
Volume 11, Issue 4, Pages e0152895
Publisher
Public Library of Science (PLoS)
Online
2016-04-13
DOI
10.1371/journal.pone.0152895
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Absorption and chemopreventive targets of sulforaphane in humans following consumption of broccoli sprouts or a myrosinase-treated broccoli sprout extract
- (2015) Lauren L. Atwell et al. MOLECULAR NUTRITION & FOOD RESEARCH
- Sickle cell disease: renal manifestations and mechanisms
- (2015) Karl A. Nath et al. Nature Reviews Nephrology
- The Triterpenoid RTA 408 is a Robust Mitigator of Hematopoietic Acute Radiation Syndrome in Mice
- (2015) Devorah C. Goldman et al. RADIATION RESEARCH
- RTA 408, A Novel Synthetic Triterpenoid with Broad Anticancer and Anti-Inflammatory Activity
- (2015) Brandon L. Probst et al. PLoS One
- Factors associated with survival in a contemporary adult sickle cell disease cohort
- (2014) Hany Elmariah et al. AMERICAN JOURNAL OF HEMATOLOGY
- Effects of Sulforaphane and 3,3′-Diindolylmethane on Genome-Wide Promoter Methylation in Normal Prostate Epithelial Cells and Prostate Cancer Cells
- (2014) Carmen P. Wong et al. PLoS One
- Effect of Broccoli Sprouts on Nasal Response to Live Attenuated Influenza Virus in Smokers: A Randomized, Double-Blind Study
- (2014) Terry L. Noah et al. PLoS One
- Sulforaphane treatment of autism spectrum disorder (ASD)
- (2014) K. Singh et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Bardoxolone Methyl in Type 2 Diabetes and Stage 4 Chronic Kidney Disease
- (2013) Dick de Zeeuw et al. NEW ENGLAND JOURNAL OF MEDICINE
- Simvastatin and t-butylhydroquinone suppress KLF1 and BCL11A gene expression and additively increase fetal hemoglobin in primary human erythroid cells
- (2012) E. R. Macari et al. BLOOD
- Hemolysis and free hemoglobin revisited: exploring hemoglobin and hemin scavengers as a novel class of therapeutic proteins
- (2012) D. J. Schaer et al. BLOOD
- Sulforaphane induces SLPI secretion in the nasal mucosa
- (2012) Megan Meyer et al. RESPIRATORY MEDICINE
- Oxidative stress in sickle cell disease; pathophysiology and potential implications for disease management
- (2011) Erfan Nur et al. AMERICAN JOURNAL OF HEMATOLOGY
- Effect of Bardoxolone Methyl on Kidney Function in Patients with T2D and Stage 3b–4 CKD
- (2011) Pablo E. Pergola et al. AMERICAN JOURNAL OF NEPHROLOGY
- Fetal hemoglobin in sickle cell anemia
- (2011) I. Akinsheye et al. BLOOD
- Induction of human fetal hemoglobin via the NRF2 antioxidant response signaling pathway
- (2011) E. R. Macari et al. BLOOD
- Bardoxolone Methyl and Kidney Function in CKD with Type 2 Diabetes
- (2011) Pablo E. Pergola et al. NEW ENGLAND JOURNAL OF MEDICINE
- Bioavailability and inter-conversion of sulforaphane and erucin in human subjects consuming broccoli sprouts or broccoli supplement in a cross-over study design
- (2011) John D. Clarke et al. PHARMACOLOGICAL RESEARCH
- microRNA miR-144 modulates oxidative stress tolerance and associates with anemia severity in sickle cell disease
- (2010) C. Sangokoya et al. BLOOD
- Sickle-cell disease
- (2010) David C Rees et al. LANCET
- The effect of prolonged administration of hydroxyurea on morbidity and mortality in adult patients with sickle cell syndromes: results of a 17-year, single-center trial (LaSHS)
- (2009) E. Voskaridou et al. BLOOD
- Sulforaphane destabilizes the androgen receptor in prostate cancer cells by inactivating histone deacetylase 6
- (2009) A. Gibbs et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Oral sulforaphane increases Phase II antioxidant enzymes in the human upper airway
- (2008) Marc A. Riedl et al. CLINICAL IMMUNOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now